Atea Pharmaceuticals

Atea develops oral antiviral therapies to address the unmet medical needs of patients with serious viral infections. 

Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2020
Stage of Initial Investment
Series D
Initial Investment Year
2020
Atea Portco Hover Image2